These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 22715068)

  • 1. Characterization of an unusual ring-contraction degradant of the antifungal agent posaconazole.
    Feng W; Hilton BD; Zhong W; Yang J; Yang X; Tong W; Martin GE
    Magn Reson Chem; 2012 Aug; 50(8):576-9. PubMed ID: 22715068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural characterization of a novel degradant of the antifungal agent posaconazole.
    Zhong W; Yang X; Tong W; Martin GE
    J Pharm Biomed Anal; 2012 Jul; 66():40-9. PubMed ID: 22464557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural characterization of the oxidative degradation products of an antifungal agent SCH 56592 by LC-NMR and LC-MS.
    Feng W; Liu H; Chen G; Malchow R; Bennett F; Lin E; Pramanik B; Chan TM
    J Pharm Biomed Anal; 2001 Jun; 25(3-4):545-57. PubMed ID: 11377035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis, molecular docking, and biological evaluation of novel triazole derivatives as antifungal agents.
    Guan Z; Chai X; Yu S; Hu H; Jiang Y; Meng Q; Wu Q
    Chem Biol Drug Des; 2010 Dec; 76(6):496-504. PubMed ID: 20973917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new, broad-spectrum azole antifungal: posaconazole--mechanisms of action and resistance, spectrum of activity.
    Hof H
    Mycoses; 2006; 49 Suppl 1():2-6. PubMed ID: 16961575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, synthesis and determination of antifungal activity of 5(6)-substituted benzotriazoles.
    Patel PD; Patel MR; Kocsis B; Kocsis E; Graham SM; Warren AR; Nicholson SM; Billack B; Fronczek FR; Talele TT
    Eur J Med Chem; 2010 Jun; 45(6):2214-22. PubMed ID: 20181413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis of novel sulfonamide-1,2,4-triazoles, 1,3,4-thiadiazoles and 1,3,4-oxadiazoles, as potential antibacterial and antifungal agents. Biological evaluation and conformational analysis studies.
    Zoumpoulakis P; Camoutsis Ch; Pairas G; Soković M; Glamočlija J; Potamitis C; Pitsas A
    Bioorg Med Chem; 2012 Feb; 20(4):1569-83. PubMed ID: 22264752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanistic study of the oxidative degradation of the triazole antifungal agent CS-758 in an amorphous form.
    Ueyama E; Suzuki N; Kano K
    J Pharm Sci; 2013 Jan; 102(1):104-13. PubMed ID: 23042572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, synthesis, and biological evaluation of novel 1, 2, 4-triazole derivatives as antifungal agent.
    Chai X; Yu S; Jiang Y; Zou Y; Wu Q; Zhang D; Jiang Y; Cao Y; Sun Q
    Arch Pharm Res; 2012 Nov; 35(11):1895-901. PubMed ID: 23212630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure determination of selaginellins G and H from Selaginella pulvinata by NMR spectroscopy.
    Cao Y; Chen JJ; Tan NH; Wu YP; Yang J; Wang Q
    Magn Reson Chem; 2010 Aug; 48(8):656-9. PubMed ID: 20623720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel antifungal agents: triazolopyridines as inhibitors of beta-1,6-glucan synthesis.
    Kuroyanagi J; Kanai K; Sugimoto Y; Fujisawa T; Morita C; Suzuki T; Kawakami K; Takemura M
    Bioorg Med Chem; 2010 Aug; 18(16):5845-54. PubMed ID: 20667743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Posaconazole: clinical pharmacology and potential for management of fungal infections.
    Groll AH; Walsh TJ
    Expert Rev Anti Infect Ther; 2005 Aug; 3(4):467-87. PubMed ID: 16107193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reviews of anti-infective agents: posaconazole: a broad-spectrum triazole antifungal agent.
    Nagappan V; Deresinski S
    Clin Infect Dis; 2007 Dec; 45(12):1610-7. PubMed ID: 18190324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The latest data on posaconazole].
    Paugam A
    Med Mal Infect; 2007 Feb; 37(2):71-6. PubMed ID: 17267154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular properties impact on bioavailability of second generation triazoles antifungal agents.
    Grudzień MK; Pałka K; Pluciński FA; Mazurek AP
    Acta Pol Pharm; 2013; 70(5):869-72. PubMed ID: 24147365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Total synthesis and conformational analysis of the antifungal agent (-)-PF1163B.
    Bouazza F; Renoux B; Bachmann C; Gesson JP
    Org Lett; 2003 Oct; 5(22):4049-52. PubMed ID: 14572246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis and structure-activity relationships of new triazole derivatives containing N-substituted phenoxypropylamino side chains.
    Wang S; Jin G; Wang W; Zhu L; Zhang Y; Dong G; Liu Y; Zhuang C; Miao Z; Yao J; Zhang W; Sheng C
    Eur J Med Chem; 2012 Jul; 53():292-9. PubMed ID: 22560626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and biological evaluation of some novel triazol-3-ones as antimicrobial agents.
    Pardeshi S; Bobade VD
    Bioorg Med Chem Lett; 2011 Nov; 21(21):6559-62. PubMed ID: 21920741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxa-ene reaction of enols of amides with 4-phenyl-1,2,4-triazoline-3,5-dione.
    Basheer A; Rappoport Z
    J Org Chem; 2008 Jan; 73(1):184-90. PubMed ID: 18072789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Homology modeling, molecular docking and spectra assay studies of sterol 14α-demethylase from Penicillium digitatum.
    Li S; Zhang J; Cao S; Han R; Yuan Y; Yang J; Yan Y; Liu D
    Biotechnol Lett; 2011 Oct; 33(10):2005-11. PubMed ID: 21660575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.